InVasc Therapeutics, Inc.

Quick facts

Marketed products

• amlodipine and olmesartan
• losartan and HCTZ · Cardiovascular
  Losartan blocks angiotensin II receptors to relax blood vessels, while HCTZ increases sodium and water excretion to reduce blood volume, together lowering blood pressure.

Phase 2 pipeline

• INV-144

Phase 1 pipeline

• accupril, alpha lipoic acid

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• InVasc Therapeutics, Inc. portfolio CI brief
• InVasc Therapeutics, Inc. pipeline updates RSS